About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
BNF Category
1: Gastro-intestinal system
2: Cardiovascular system
3: Respiratory system
4: Central nervous system
5: Infections
6: Endocrine system
7: Obstetrics, gynaecology, and urinary-tract disorders
8: Malignant disease and immunosuppression
9: Nutrition and blood
10: Musculoskeletal and joint diseases
11: Eye
12: Ear, nose, and oropharynx
13: Skin
14: Immunological products and vaccines
15: Anaesthesia
Appendix 7
Appendix 8 Wound management products and elasticated garments
Non-BNF miscellaneous
Emergency treatment of poisoning
5.1 Antibacterial drugs
5.2 Antifungal drugs
5.3 Antiviral drugs
5.4 Antiprotozoal drugs
5.5 Anthelmintics
5.3.1 HIV infection
5.3.2 Herpesvirus infections
5.3.3 Viral hepatitis
5.3.4 Influenza
5.3.5 Respiratory syncytial virus
40 library items
in 5.3.5 Respiratory syncytial virus
Filter results by:
Date Published
2012 (1)
2011 (5)
2010 (11)
2009 (6)
2008 (8)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
5: Infections (
remove
)
,
5.3 Antiviral drugs (
remove
)
,
5.3.5 Respiratory syncytial virus (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 40
Result page:
Previous
|
1
2
3
4
|
Next
1.
Use of palivizumab in primary practice
Source:
Pediatrics
,
Date published:
12/01/2012
Category:
5.3.5 Respiratory syncytial virus
NeLM
Area:
Evidence
>
Medicines Management
>
References
Abstract link
2.
Copegus 200mg and 400mg Film-coated Tablets (Ribavirin)- Revised SPC
Source:
eMC (electronic Medicines Compendium)
,
Date published:
07/12/2011
Category:
5.3.5 Respiratory syncytial virus
|
Hepatitis and other gastrointestinal infections
|
Product Licence Changes
NeLM
Area:
Other Library Updates
>
SPC Changes
SPC
3.
Updates to influenza and RSV chapters of the Green Book
Source:
Department of Health (DH)
,
Date published:
16/09/2011
Category:
5.3.5 Respiratory syncytial virus
|
14.4 Vaccines and antisera
|
Department of Health (DH)
|
Other respiratory infections
|
Vaccination
NeLM
Area:
News
Link to influenza update
Link to RSV update
4.
Copegus 200mg and 400mg Film Coated Tablets (ribavarin) - Revised SPC
Source:
eMC (electronic Medicines Compendium)
,
Date published:
18/04/2011
Category:
5.3.5 Respiratory syncytial virus
|
Product Licence Changes
|
Viral
NeLM
Area:
Other Library Updates
>
SPC Changes
Link to SPC
5.
Updated national IV monograph on Ribavirin (Virazole®)
Source:
Medusa
,
Date published:
01/03/2011
Category:
5.3.5 Respiratory syncytial virus
|
Drug Administration
NeLM
Area:
News
Link- registration required
Link to FAQ on MEDUSA
6.
HTA systematic review: Palivizumab for immunoprophylaxis of RSV bronchiolitis in high-risk infants and young children
Source:
Health Technology Assessment (HTA)
,
Date published:
14/02/2011
Category:
5.3.5 Respiratory syncytial virus
|
Drugs in paediatrics
|
Paediatrics
|
Respiratory Medicine
|
Viral
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
7.
AstraZeneca ends development of motavizumab for prevention of RSV
Source:
PharmaTimes
,
Date published:
21/12/2010
Category:
5.3.5 Respiratory syncytial virus
|
Food &Drug Administration (FDA)
|
New drugs
|
Product Discontinuation
|
Viral
NeLM
Area:
News
Link-registration required
8.
Use of ribavirin in pregnancy
Source:
UK Teratology Information Service
,
Date published:
20/10/2010
Category:
5.3.3 Viral hepatitis
|
5.3.5 Respiratory syncytial virus
|
Drugs in pregnancy
NeLM
Area:
Evidence
>
Drugs in Pregnancy
9.
CAS communication: Recommendations for use of passive immunisation palivizumab (Synagis®) for prophylaxis of Respiratory Syncytial Virus
Source:
CAS
,
Date published:
08/10/2010
Category:
5.3.5 Respiratory syncytial virus
|
Department of Health (DH)
|
Paediatrics
|
Prescribing and supply of medicines
|
Respiratory Medicine
|
Viral
NeLM
Area:
News
Link to letter
Link to Excel tool
10.
Annual Evidence Update on Hepatitis B and C: 26-30 July 2010
Source:
NHS Evidence
,
Date published:
26/07/2010
Category:
5.3.3 Viral hepatitis
|
5.3.5 Respiratory syncytial virus
|
8.2.4 Other immunomodulating drugs
|
Hepatitis and other gastrointestinal infections
|
Information provision
NeLM
Area:
News
Link
Results 1 - 10 of 40
Result page:
Previous
|
1
2
3
4
|
Next